Carfilzomib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Carfilzomib and local guidelines before prescribing.

Proteasome inhibitor

Mechanism

Proteasome inhibitor.

Uses

Relapsed multiple myeloma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Cardiac failure, hypertension, dyspnoea, thrombocytopenia, tumour lysis.

Interactions

Few.

Contraindications and cautions

Cardiac disease caution

Monitoring

FBC, BP, cardiac assessment

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Hydrate and monitor cardiac status.

More from the textbook: uses, cautions and other points
Where it is discussed in the book